Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discontinuation of oral antivirals in chronic hepatitis B: A systematic review
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 63, Issue 5, Pages 1481-1492
Publisher
Wiley
Online
2016-01-11
DOI
10.1002/hep.28438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs
- (2015) Jian-ning Jiang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)
- (2015) T. Berg et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides
- (2014) V. R. Patwardhan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
- (2014) Hyung Rae Sohn et al. BMC INFECTIOUS DISEASES
- Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
- (2014) D. He et al. CLINICAL MICROBIOLOGY AND INFECTION
- Discontinuation of long-term NA therapy in HBeAg-negative chronic hepatitis B
- (2014) Stephanos Hadziyannis et al. GUT
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
- (2014) Wai-Kay Seto et al. GUT
- The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment
- (2014) Chien-Hung Chen et al. JOURNAL OF HEPATOLOGY
- Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
- (2014) Jorg Petersen et al. LIVER INTERNATIONAL
- Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative
- (2013) Dengming He et al. BMC INFECTIOUS DISEASES
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Relapse of chronic hepatitis B after discontinuation of nucleos(t)ide analogs: Is the glass half full or half empty?
- (2013) Jurriën G.P. Reijnders et al. HEPATOLOGY
- Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir
- (2013) E. Ridruejo et al. JOURNAL OF VIRAL HEPATITIS
- Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
- (2013) George V. Papatheodoridis LIVER INTERNATIONAL
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
- (2012) Kevin T. Chaung et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?
- (2012) Jung Hyun Kwon et al. JOURNAL OF MEDICAL VIROLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Two-stage meta-analysis of survival data from individual participants using percentile ratios
- (2012) Jessica K. Barrett et al. STATISTICS IN MEDICINE
- Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B
- (2012) Myeong Jun Song WORLD JOURNAL OF GASTROENTEROLOGY
- Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
- (2011) Henry L-Y Chan et al. ANTIVIRAL THERAPY
- A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir
- (2011) Minghao Ha et al. ARCHIVES OF VIROLOGY
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
- (2010) Wei Cai et al. JOURNAL OF CLINICAL VIROLOGY
- Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
- (2010) Feng Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
- (2009) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
- (2009) Chau-Ting Yeh et al. JOURNAL OF CLINICAL VIROLOGY
- Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
- (2009) L. Wang et al. JOURNAL OF VIRAL HEPATITIS
- Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion
- (2009) Yuan-Hung Kuo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial
- (2008) Masaru Enomoto et al. HEPATOLOGY RESEARCH
- Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
- (2007) George V Papatheodoridis et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More